PREDICTIVE TECHNOLOGY GROUP, INC.
PREDICTIVE TECHNOLOGY GROUP, INC. (PRED): 2 pipeline candidates · ~3 mo cash runway · 3 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
2.5 months
D/E 1.09 · 0% dilution
Lead: Approved
2 candidates
N/A
N/A
A transparent, data-derived signal for PREDICTIVE TECHNOLOGY GROUP, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
—
Cash
$152K
Quarterly Burn
$3.4M
Runway
2.5 mo
Revenue
$6.9M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (2 candidates)
| Drug | Phase |
|---|---|
| artguide | Approved |
| fertilitydx | Approved |
Frequently asked questions
How many drug candidates are in PREDICTIVE TECHNOLOGY GROUP, INC.'s pipeline?
PREDICTIVE TECHNOLOGY GROUP, INC. (PRED) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is PREDICTIVE TECHNOLOGY GROUP, INC.'s lead drug candidate?
PREDICTIVE TECHNOLOGY GROUP, INC.'s most advanced tracked candidate is artguide (Approved) for Infertility resulting from endometriosis and other genetic conditions.
What is PREDICTIVE TECHNOLOGY GROUP, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, PREDICTIVE TECHNOLOGY GROUP, INC. has approximately 2.5 months of cash runway.
Get the full picture on PREDICTIVE TECHNOLOGY GROUP, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.